Compare CDMOs with DEA registration for manufacturing controlled substances (Schedule II-V). Filter by schedule classification, dosage form, and security capabilities.
2 companies listed
Manufacturing controlled substances (Schedules II-V under the Controlled Substances Act) requires DEA registration and compliance with strict security, inventory, and record-keeping requirements. CDMOs handling these substances must maintain vault storage, electronic access controls, perpetual inventory systems, annual production quotas from DEA, and employee background screening programs.
Demand for controlled substance CDMO capacity is growing, driven by: pain management products (abuse-deterrent opioid formulations), CNS medications (ADHD treatments, anxiolytics, sleep aids), psychedelic-derived therapies (psilocybin, MDMA -- currently Schedule I, potentially rescheduled), and medical cannabis-derived products. The regulatory burden of DEA compliance limits the number of CDMOs willing to handle these compounds.
Our AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.